SPY749.60−0.63%QQQ674.25−0.83%BTC/USD66,913.00−1.93%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

Vanda Pharmaceuticals Inc

VNDANASDAQ

Trade with Public

$3.99

0.041.01%

At close: Nov 13, 4:00 PM EST

$3.99

N/A

After Hours: 4:00 PM EST

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Vanda Pharmaceuticals (VNDA) stock.

Analyst Consensus — 6 Analysts

5Buy

1Hold

# Analysts6

Latest Upgrades and Downgrades for Vanda Pharmaceuticals Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
—	Oppenheimer	Les Sulewski	Initiate	Outperform	$10
—	B. Riley Securities	Madison El-Saadi	PT Cut	Buy	$17→$12
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$21→$20
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$24→$21
—	Truist Securities	Les Sulewski	Initiate	Buy	$18
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$22→$24
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$20→$22
—	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$11→$14
—	Jefferies	Chris Howerton	PT Raise	Hold	$5→$8
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
—	B. Riley Securities	Madison El-Saadi	Initiate	Buy	$11
—	Cantor Fitzgerald	Olivia Brayer	PT Cut	Overweight	$13→$11
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
—	Cantor Fitzgerald	Olivia Brayer	Assumes	Overweight	$13
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$18→$20
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$18
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$18

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

Latest Upgrades and Downgrades for Vanda Pharmaceuticals Stock

Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

Latest Upgrades and Downgrades for Vanda Pharmaceuticals Stock

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PRO
Oppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PRO
B. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21

This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

People Also Watch

People Also Watch

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PRO
Oppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PRO
B. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21

This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

Latest Upgrades and Downgrades for Vanda Pharmaceuticals Stock

Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

Latest Upgrades and Downgrades for Vanda Pharmaceuticals Stock

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PROOppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PROB. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PROHC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PROHC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21

This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

People Also Watch

People Also Watch

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PROOppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PROB. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PROHC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PROHC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21

This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
HC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PRO
Oppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PRO
B. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21

PRO
HC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target

PRO
Oppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10

PRO
B. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21